EMA Authorised: Telmisartan Teva Pharma (telmisartan) — Teva B.V.

View source ↗

Summary

The EMA authorised Telmisartan Teva Pharma (telmisartan) for hypertension, with Teva B.V. as the marketing authorization holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan Teva Pharma (telmisartan)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Teva B.V.. Decision date: 08/10/2021